Actavis survives challenge to birth control pill

21-01-2014

Actavis survives challenge to birth control pill

Photo: Calek / Shutterstock.com

On January 17, Actavis confirmed that the US District Court for the District of New Jersey found its US patent 7,704,984, which covers Lo Loestrin Fe birth control pills, to be valid and infringed by Lupin Pharmaceuticals and Amneal Pharmaceuticals.


Actavis, Lupin, Amneal, Lo Loestrin Fe, patent challenge

LSIPR